𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparative molecular field analysis (CoMFA) of a series of selective adenosine receptor A2A antagonists

✍ Scribed by Pier Giovanni Baraldi; Pier Andrea Borea; Manuela Bergonzoni; Barbara Cacciari; Ennio Ongini; Maurizio Recanatini; Giampiero Spalluto


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
304 KB
Volume
46
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

✦ Synopsis


Selective and potent antagonists for the A 2A adenosine receptors have been described recently. The most potent compounds have a triazolo-pyrimidine structure, whereas 8-styryl-xanthines usually possess lower affinity at the A 2A receptor. We have examined the quantitative structure activity relationships of 34 triazolo-pyrimidines using the Comparative Molecular Field Analysis (CoMFA). The model developed accounts in a satisfactory manner for the structure-activity relationships within this series of A 2A receptor antagonists (q 2 = 0.840, r 2 = 0.970) and, consequently, it can be used as a guide in the design of novel analogs with optimized antagonistic activity. The overall predictivity of this model was tested on the published data of a set of external molecules giving acceptable results. The validity of the CoMFA approach as an effective tool for studying the 3D-QSAR of series of biologically active compounds is confirmed, even if additional efforts clearly are needed for trying to extend the models to structurally more varied series of derivatives. Drug Dev. Res. 46:126-133, 1999.


πŸ“œ SIMILAR VOLUMES


A2A-selective adenosine receptor antagon
✍ Christa E. MΓΌller; Roland Sauer; Yuris Maurinsh; Rosa Huertas; Friederike FΓΌlle; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 214 KB πŸ‘ 2 views

A 2A adenosine receptor (AR) antagonists are promising new drugs for the treatment of Parkinson's disease. Further potential therapeutic indications for A 2A AR antagonists include dementias, ischemias, and pain. Potent, selective A 2A AR antagonists have been developed, but their generally low wate

Acyl-hydrazide derivatives of a xanthine
✍ Yong-Chul Kim; Yishai Karton; Xiao-duo Ji; Neli Melman; Joel Linden; Kenneth A. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 334 KB πŸ‘ 1 views

The structure-activity relationships (SAR) of 8-phenyl-1,3-dipropylxanthine derivatives in binding to recombinant human A 2B adenosine receptors were explored, in order to identify selective antagonists. Based on the finding of receptor selectivity in MRS 1204, containing an N-hydroxysuccinimide est

Potent antagonists for the human adenosi
✍ Maarten de Zwart; Roel C. Vollinga; Margot W. Beukers; Danielle F. Sleegers; Jac πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 2 views

A series of novel and known 5-substituted 7-amino-2-(2-furyl) [1,2,4]triazolo [1,5a][1,3,5]triazine derivatives were synthesized and tested for adenosine receptor antagonism in radioligand binding assays at all four adenosine receptor subtypes and for inhibition of the agonist-induced cyclic AMP res

Synthesis of the tritium labeled SCH 582
✍ Pier Giovanni Baraldi; Barbara Cacciari; Silvio Dionisotti; Judith Egan; Giampie πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 375 KB πŸ‘ 1 views

The tritium labeled form of 5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo[4,3-e] 1,2,4-triazolo[l,5-c]pyrimidine (3H-SCH 58261) was obtained by reduction of 5-amino-7-[2-(2',4',5'-tribromo)phenylethyl]-2-(2-furyl)-pyrazolo[4,3-e] 1,2,4-triazolo[ 1,5clpyrimidine with tritium gas in the presence of 10